|
| 36753459 | Predictors and Etiologies of Clinical Relapse Among Patients With Ulcerative Colitis in Deep Remission. | J Clin Gastroenterol | 2024 |
| 37716619 | Withdrawal of Immunomodulators or TNF Antagonists in Patients With Inflammatory Bowel Diseases in Remission on Combination Therapy: A Systematic Review and Meta-analysis. | Clin Gastroenterol Hepatol | 2024 |
| 37913893 | Quantifying Endoscopic Activity in Ulcerative Colitis: Innovation, Powered by Artificial Intelligence. | Gastroenterology | 2024 |
| 37707480 | Temporary Faecal Diversion for Refractory Perianal and/or Distal Colonic Crohn's Disease in the Biologic Era: An Updated Systematic Review with Meta-analysis. | J Crohns Colitis | 2024 |
| 37879517 | Common Instances of Low-value Care in Inflammatory Bowel Diseases. | Clin Gastroenterol Hepatol | 2024 |
| 37821035 | Risk of Major Adverse Cardiovascular Events in Immune-Mediated Inflammatory Disorders on Biologics and Small Molecules: Network Meta-Analysis. | Clin Gastroenterol Hepatol | 2024 |
| 37002875 | Endoscopic and Histological Placebo Rates in Crohn's Disease Clinical Trials: A Systematic Review and Meta-analysis. | Inflamm Bowel Dis | 2024 |
| 34864789 | Outcomes of Fecal Microbiota Transplantation for C. difficile Infection in Inflammatory Bowel Disease : A Systematic Review and Meta-analysis. | J Clin Gastroenterol | 2023 |
| 37589567 | Approval Timelines for Advanced Therapeutics in Inflammatory Bowel Disease: A Comparison Between the European Medicines Agency and the Food and Drug Administration. | Inflamm Bowel Dis | 2023 |
| 37585204 | Patterns in Cancer Incidence Among People Younger Than 50 Years in the US, 2010 to 2019. | JAMA Netw Open | 2023 |
| 37578211 | A Comparison of Treatment Effect Sizes in Matched Phase 2 and Phase 3 Trials of Advanced Therapeutics in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis. | Clin Transl Gastroenterol | 2023 |
| 37981354 | AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Crohn's Disease. | Gastroenterology | 2023 |
| 35704691 | A Serum Biomarker Panel Can Accurately Identify Mucosal Ulcers in Patients With Crohn's Disease. | Inflamm Bowel Dis | 2023 |
| 35644340 | Effectiveness and Safety of Biologic Therapy in Hispanic Vs Non-Hispanic Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study. | Clin Gastroenterol Hepatol | 2023 |
| 35749316 | Comparison of the Relative Sensitivity of Clinical, Endoscopic, and Histologic Remission for Detection of Treatment Efficacy in Ulcerative Colitis Trials. | Inflamm Bowel Dis | 2023 |
| 37061107 | HLA-DQA1⿿05 Genotype and Immunogenicity to Tumor Necrosis Factor-α Antagonists: A Systematic Review and Meta-analysis. | Clin Gastroenterol Hepatol | 2023 |
| 37317532 | Efficacy and Safety of Advanced Oral Small Molecules for Inflammatory Bowel Disease: Systematic Review and Meta-Analysis. | J Crohns Colitis | 2023 |
| 37246609 | Systematic review and meta-analysis of randomised controlled trials: Medical therapies for the treatment and prevention of pouchitis. | Aliment Pharmacol Ther | 2023 |
| 36976548 | Comparative Speed of Early Symptomatic Remission With Advanced Therapies for Moderate-to-Severe Ulcerative Colitis: A Systematic Review and Network Meta-Analysis. | Am J Gastroenterol | 2023 |
| 37378711 | Efficacy and Safety of IL-12/23 and IL-23 Inhibitors for Crohn's Disease: Systematic Review and Meta-Analysis. | Dig Dis Sci | 2023 |
| 37207296 | Early Remission With Induction Therapy Predicts Long-Term Remission in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. | Am J Gastroenterol | 2023 |
| 37268795 | Correlations Between Gastrointestinal Symptoms and Endoscopic-Histologic Disease Activity in Adults with Ulcerative Colitis. | Dig Dis Sci | 2023 |
| 37001765 | Estimated Burden of Screening for Barrett's Esophagus in the United States. | Gastroenterology | 2023 |
| 36623171 | Prevalence and Correlations of Gastrointestinal Symptoms With Endoscopic and Histologic Mucosal Healing in Crohn's Disease. | Am J Gastroenterol | 2023 |
| 36622750 | Conventional Frailty Index Does Not Predict Risk of Postoperative Complications in Patients With IBD: A Multicenter Cohort Study. | Dis Colon Rectum | 2023 |
| 36871771 | Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-analysis. | Clin Gastroenterol Hepatol | 2023 |
| 36576029 | Burden, Causes, and Outcomes of Hospitalization in Patients With Giant Cell Arteritis: A US National Cohort Study. | Arthritis Care Res (Hoboken) | 2023 |
| 36804992 | To Combine or Not to Combine: Do We Need Concomitant Immunomodulators When Using Non-TNF-Targeting Biologics? | Clin Gastroenterol Hepatol | 2023 |
| 36707727 | Positioning therapies for the management of inflammatory bowel disease. | Nat Rev Gastroenterol Hepatol | 2023 |
| 36825479 | Meta-analysis: Placebo rates in microscopic colitis randomised trials and applications for future drug development using a historical control arm. | Aliment Pharmacol Ther | 2023 |
| 36669515 | Management of inflammatory bowel diseases in older adults. | Lancet Gastroenterol Hepatol | 2023 |
| 36863633 | Evidence Synthesis to Advance Clinical Practice and Scientific Research: A CGH Pillar. | Clin Gastroenterol Hepatol | 2023 |
| 36757156 | Patients With Crohn's Disease and Permanent Ileostomy Are Universally Excluded From Clinical Trials: A Systematic Review. | Am J Gastroenterol | 2023 |
| 36658773 | Autologous fat graft injections for the treatment of perianal fistulas in Crohn's disease: a systematic review and single-arm meta-analysis. | ANZ J Surg | 2023 |
| 36822736 | AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis. | Gastroenterology | 2023 |
| 36179129 | Concordance and Discordance Between Patient-reported Remission, Patient-reported Outcomes, and Physician Global Assessment. | Inflamm Bowel Dis | 2023 |
| 35930405 | Placebo Rates in Randomized Controlled Trials of Proctitis Therapy: A Systematic Review and Meta-Analysis Placebo Response in Proctitis. | J Crohns Colitis | 2023 |
| 36219564 | Most Placebo-Controlled Trials in Inflammatory Bowel Disease were Underpowered Because of Overestimated Drug Efficacy Rates: Results from a Systematic Review of Induction Studies. | J Crohns Colitis | 2023 |
| 35944832 | Comparative Risk of Serious Infections With Biologic Agents and Oral Small Molecules in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. | Clin Gastroenterol Hepatol | 2023 |
| 36343846 | Comparative Safety and Effectiveness of Biologic Therapy for Crohn's Disease: A CA-IBD Cohort Study. | Clin Gastroenterol Hepatol | 2023 |
| 33039584 | Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis. | Clin Gastroenterol Hepatol | 2022 |
| 35348692 | Natural History of New-onset Inflammatory Bowel Disease Among Patients With Multiple Sclerosis. | Inflamm Bowel Dis | 2022 |
| 35347100 | Preserved SARS-CoV-2 Vaccine Cell-Mediated Immunogenicity in Patients With Inflammatory Bowel Disease on Immune-Modulating Therapies. | Clin Transl Gastroenterol | 2022 |
| 35503486 | Impact of Comorbid Psychiatric Disorders on Healthcare Utilization in Patients with Inflammatory Bowel Disease: A Nationally Representative Cohort Study. | Dig Dis Sci | 2022 |
| 35762693 | Comparative efficacy trials in inflammatory bowel disease: current and future implications for practice. | Curr Opin Gastroenterol | 2022 |
| 35788348 | CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease. | Gastroenterology | 2022 |
| 35753383 | Proactive Therapeutic Drug Monitoring Versus Conventional Management for Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. | Gastroenterology | 2022 |
| 36518884 | Impact of recurrent hospitalization for <i>Clostridioides difficile</i> on longitudinal outcomes in patients with inflammatory bowel diseases: a nationally representative cohort. | Therap Adv Gastroenterol | 2022 |
| 35973139 | Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study. | Am J Gastroenterol | 2022 |
| 35905414 | Simplified Machine Learning Models Can Accurately Identify High-Need High-Cost Patients With Inflammatory Bowel Disease. | Clin Transl Gastroenterol | 2022 |